George D. Yancopoulos
2011
In 2011, George D. Yancopoulos earned a total compensation of $10M as President, Regeneron Laboratories and Chief Scientific Officer at Regeneron Pharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
| Bonus | $1,897,300 |
|---|---|
| Option Awards | $7,450,200 |
| Salary | $652,700 |
| Other | $26,770 |
| Total | $10,026,970 |
Yancopoulos received $7.5M in option awards, accounting for 74% of the total pay in 2011.
Yancopoulos also received $1.9M in bonus, $652.7K in salary and $26.8K in other compensation.
Rankings
In 2011, George D. Yancopoulos' compensation ranked 360th out of 10,747 executives tracked by ExecPay. In other words, Yancopoulos earned more than 96.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 360 out of 10,747 | 97th |
Division Manufacturing | 120 out of 3,958 | 97th |
Major group Chemicals And Allied Products | 27 out of 1,034 | 97th |
Industry group Drugs | 15 out of 782 | 98th |
Industry Pharmaceutical Preparations | 13 out of 567 | 98th |
Source: SEC filing on April 24, 2014.
Yancopoulos' colleagues
We found three more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2011.
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019